Veritas Pharma Inc Stock Price - VRTHF

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$30.03
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
SMALL CAP PRO
Monthly Subscription
for only
$44.59
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Veritas Pharma (PC) VRTHF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.046722 +7.65% 0.657712 0.6862 0.6025 0.6025 0.61099 16:24:32
Bid Price Ask Price Spread Spread % News
0.63 0.674 0.044 6.53% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
82 101,306 $ 0.6311 $ 63.94k 248.29k 0.22 - 0.88
Last Trade Time Type Quantity Stock Price Currency
15:59:27 300 $0.66 USD

Veritas Pharma (PC) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 25.24M 38.71M $ -2.93M - -8.61 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Veritas Pharma (PC) News

Latest VRTHF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VRTHF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.680.75290.60250.6553140k309k222k-0.022288-3.28%
1 Month0.49550.8810.46460.7042100k2M448k0.16221232.74%
3 Months0.3650.8810.2950.6459502M275k0.29271280.20%
6 Months0.311490.8810.220.623102M131k0.346222111.15%
1 Year0.3480.8810.220.568502M83k0.30971289.00%
3 Years0.3770.8810.1040.483702M69k0.28071274.46%
5 Years0.3770.8810.1040.483702M69k0.28071274.46%

Veritas Pharma (PC) Description

The medical marijuana industry is projected to have substantial growth over the next few years and Veritas is among the first to employ a comprehensive scientific approach behind medical marijuana claims. Our mission is to develop the most effective proprietary cannabis strains for specific disease conditions providing doctors and patients with conclusive scientific evidence for the recommendation and use of medical marijuana with confidence. Veritas has formed an exclusive partnership and investment in Cannevert Therapeutics, a high-level research and development company, with its main office on the University of British Columbia (UBC) campus. Cannevert has brought together a highly accredited team of pharmacologists, anaesthetists and chemists with proven track records of success in drug development in both academia and industry. This alliance will provide Veritas with the required technical ability to achieve its goals in research, development and commercialization.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.